Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up study.
Saved in:
| Title: | Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up study. |
|---|---|
| Authors: | Picconi O; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Sgadari C; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Tripiciano A; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Moretti S; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Maggiorella MT; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Francavilla V; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Casabianca A; Department of Biomolecular Science, University of Urbino, Urbino, Italy., Orlandi C; Department of Biomolecular Science, University of Urbino, Urbino, Italy., Belli R; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Palladino C; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Campagna M; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Mancini F; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Sernicola L; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Pavone Cossut MR; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Pimpinelli F; Laboratory of Microbiology and Virology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy., Magnani M; Department of Biomolecular Science, University of Urbino, Urbino, Italy., Ensoli F; Laboratory of Clinical Pathology and Microbiology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy., Mathebula M; Mecru Clinical Research Unit (MeCRU), Sefako Makgatho Health Sciences University (SMU), Gauteng, South Africa., Cafaro A; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Monini P; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy., Nchabeleng M; Mecru Clinical Research Unit (MeCRU), Sefako Makgatho Health Sciences University (SMU), Gauteng, South Africa.; National Health Service, Dr George Mukhari Microbiology Laboratory, Pretoria, South Africa., Ensoli B; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Apr 10; Vol. 17, pp. 1769223. Date of Electronic Publication: 2026 Apr 10 (Print Publication: 2026). |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1769223 |
